Measles clinical trials
The registry lists 120 studies for Measles across more than 10 countries. 17 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-24.
Status
- Completed
- 83
- Status unknown
- 13
- Recruiting
- 9
- Not yet recruiting
- 8
- Terminated
- 5
- Active, not recruiting
- 1
Phase
- Phase 3
- 36
- Phase 4
- 27
- Phase 2
- 17
- Phase 1
- 7
Where
- United States
- 26
- Guinea-Bissau
- 10
- Puerto Rico
- 9
- Germany
- 8
- China
- 7
- Taiwan
- 6
Who runs them
GlaxoSmithKline (23) · Merck Sharp & Dohme LLC (13) · Bandim Health Project (10) · The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) (6) · Sanofi Pasteur, a Sanofi Company (5) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · PATH (3) · Centers for Disease Control and Prevention, China (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 120 — search for more.
- Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation PatientsRecruitingNCT07195032Phase 41 country
- A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of AgeNot yet recruitingNCT07742644Phase 36 countries
- A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of AgeRecruitingNCT07406360Phase 31 country
- Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveRecruitingNCT073589101 country
- the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L VaccinesNot yet recruitingNCT073388511 country
- The Effects of Iron Treatment on Malaria and Measles Vaccine Response in Kenyan Infants With Iron DeficiencyNot yet recruitingNCT06816524Not applicable
- Unravelling the Measles Paradox (MISIA)RecruitingNCT072675851 country
- Unravelling the Measles Paradox in ChildrenNot yet recruitingNCT069236311 country
- Prospective Clinical Registry for Evaluation of Exanthematous Infections and CoinfectionsNot yet recruitingNCT07112846
- Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 MonthsNot yet recruitingNCT06815835Phase 31 country
- Earlier Prime-BOOST Schedule to Improve MEasles Protection in High Burden SettingsRecruitingNCT06667206Phase 21 country
- Measles and BCG Vaccines for Mother and ChildRecruitingNCT04899765Phase 41 country
- Immunity in Persons Fully Vaccinated Against Measles, Mumps and Rubella and Responses to Booster VaccinationRecruitingNCT05894395Phase 31 country
- Co-administration Study of OCV, TCV and MRNot yet recruitingNCT05771779Phase 3
- Monitoring of Measles-specific Immune Status in Adult Allogeneic Hematopoietic Stem Cell Transplant RecipientsRecruitingNCT05947864Not applicable1 country
- Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated VaccinesNot yet recruitingNCT05952505Phase 41 country
- Induction of Immunity Against Measles in Pediatric Liver Transplant RecipientsRecruitingNCT01770119Phase 41 country
- Clinical Diagnostic Performance Evaluation of a Measles Rapid Test in SenegalTerminatedNCT058609201 country
- Increasing Measles Vaccination Coverage Through Supplementation With an SQ-LNS Incentive in Children Aged 6-23 MonthsCompletedNCT06387511Not applicable1 country
- Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMRCompletedNCT02325310Phase 41 country
- Predictors of Measles Vaccine Hesitancy in New York StateCompletedNCT073730931 country
- Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 MonthsCompletedNCT06399003Phase 31 country
- Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)CompletedNCT06331702Phase 41 country
- Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of AgeCompletedNCT03071575Phase 41 country
- A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of AgeCompletedNCT05630846Phase 25 countries
- Barriers and Facilitators to MMR Vaccination Among Healthcare WorkersCompletedNCT064567881 country
- A Tool Kit to Improve Vaccine Confidence in the PhilippinesActive, not recruitingNCT06218368Not applicable1 country
- Evaluation of Pediatric Measles Cases in 2019: Single-Center ExperienceCompletedNCT056147911 country
- Vaccine Campaign Effects on General Hospital Admissions and Mortality Among ChildrenCompletedNCT03460002Phase 41 country
- Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRTCompletedNCT02962167Phase 11 country
- A Second Dose of Measles Vaccine (MV) in the Second Year of LifeCompletedNCT02943681Not applicable1 country
- Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With AtezolizumabTerminatedNCT02919449Phase 11 country
- Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases ConfirmedCompletedNCT055927561 country
- Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control TrialStatus unknownNCT05803538Not applicable1 country
- Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation TrialCompletedNCT04394689Phase 1/21 country
- Ontogeny of Measles Immunity in InfantsCompletedNCT002409161 country
- The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella VaccineStatus unknownNCT05279248Phase 41 country
- Immunity Duration Study Eight Years After Vaccination of Children 12 to 23 Months With the Triple Viral Vaccine (Measles, Mumps and Rubella)Status unknownNCT05154097
- Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV DrugsCompletedNCT00013871Not applicable2 countries
- A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials GroupCompletedNCT00000815Phase 22 countries
- Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route (V205C-011)CompletedNCT00432523Phase 32 countries
- Measles, Mumps, and Rubella (MMR) Immunity in College StudentsCompletedNCT009628191 country
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of LifeCompletedNCT01681992Phase 37 countries
- Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of AgeCompletedNCT02184572Phase 35 countries
- Phase I Trial of Measles Vectored Chikungungya VaccineCompletedNCT03028441Phase 11 country
- UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles VirusCompletedNCT02192775Phase 21 country
- Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) VaccineCompletedNCT02880865Phase 41 country
- Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and RubellaCompletedNCT03148990Phase 2/31 country
- Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by COVID-19 in OECD Countries?CompletedNCT044688021 country
- Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A VaccineStatus unknownNCT03330171Phase 41 country